NEUTROPENIA
Clinical trials for NEUTROPENIA explained in plain language.
Never miss a new study
Get alerted when new NEUTROPENIA trials appear
Sign up with your email to follow new studies for NEUTROPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to boost immune cells in rare blood disorder
Disease control Recruiting nowThis Phase 3 study tests whether the drug mavorixafor can reduce serious infections and increase neutrophil levels in people with chronic neutropenia—a condition where the body doesn't make enough infection-fighting white blood cells. About 176 participants will receive either ma…
Matched conditions: NEUTROPENIA
Phase: PHASE3 • Sponsor: X4 Pharmaceuticals • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new protein drug shield kids with cancer from dangerous infections?
Disease control Recruiting nowThis trial tests whether a new drug called albipagrastim alfa can prevent severe neutropenia (dangerously low white blood cell counts) in children with sarcoma who are receiving chemotherapy. The drug is designed to stimulate the body's production of infection-fighting neutrophil…
Matched conditions: NEUTROPENIA
Phase: PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a safer dose of an old drug shield vulnerable children from deadly fungal infections?
Disease control Recruiting nowThis trial tests whether a low dose of the antifungal drug liposomal amphotericin B can prevent invasive fungal infections in children aged 3 to 17 who have prolonged neutropenia (very low white blood cell counts) after cancer treatment or stem cell transplant. The drug is given …
Matched conditions: NEUTROPENIA
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New antibiotic could shield blood cancer patients from deadly infections
Disease control Recruiting nowThis study is for people with blood cancers like leukemia who are getting chemotherapy or a stem cell transplant, which can cause very low white blood cell counts (neutropenia) for over a week. The goal is to see if the antibiotic eravacycline can prevent serious bacterial infect…
Matched conditions: NEUTROPENIA
Phase: PHASE2 • Sponsor: West Virginia University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a single drug boost blood counts and delay cancer in High-Risk patients?
Disease control Recruiting nowThis study tests the drug luspatercept in 50 adults with clonal cytopenias of uncertain significance (CCUS), a condition where low blood cell counts increase the risk of developing blood cancers like leukemia. Participants receive injections every three weeks for up to 48 weeks. …
Matched conditions: NEUTROPENIA
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
Prevention Recruiting nowThis study looks at whether a low dose of the antifungal drug liposomal amphotericin B can prevent serious fungal infections in adults with blood cancers or who have had stem cell transplants and have a prolonged low white blood cell count (neutropenia). The trial enrolls 30 pati…
Matched conditions: NEUTROPENIA
Sponsor: Haikou Affiliated Hospital of Central South University Xiangya School of Medicine • Aim: Prevention
Last updated Aug 15, 2026 00:00 UTC
-
New drug may shield cancer patients from dangerous infection risk
Prevention Recruiting nowThis real-world study looks at whether a drug called mecapegfilgrastim can prevent neutropenia (a low white blood cell count) in cancer patients after chemotherapy, radiation, or immunotherapy. The study will follow 200 adults with solid tumors who are at high or moderate risk of…
Matched conditions: NEUTROPENIA
Sponsor: Hebei Medical University Fourth Hospital • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Allergy drug and supplement face off in battle against cancer treatment bone pain
Symptom relief Recruiting nowThis study tests two oral medications—diosmin-hesperidin (a flavonoid supplement) and loratadine (an allergy drug)—to prevent bone pain caused by G-CSF, a drug that boosts white blood cells in blood cancer patients. Researchers will compare each drug alone and in combination agai…
Matched conditions: NEUTROPENIA
Phase: NA • Sponsor: Alexandria University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC